Related Experiment Video
Updated: Nov 23, 2025
07:59
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
10.1K
Boesenmaxane Diterpenoids from Boesenbergia maxwellii
The S Moe1, Suppisak Chaturonrutsamee2, Samreang Bunteang
1Pharmaceutical Research Laboratory, Biotechnology Research Department, Ministry of Education, Mandalay Division, Kyaukse 05151, Myanmar.
Journal of Natural Products
|December 29, 2020
Summary
Three new compounds, boesenmaxanes A-C, were isolated from Boesenbergia maxwellii. Boesenmaxanes A and C demonstrated significant anti-HIV activity, highlighting their potential therapeutic value.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Organic Chemistry
Background:
- Boesenbergia maxwellii rhizomes are a source of bioactive compounds.
- Diterpenoids with unique skeletons are of interest for drug discovery.
Purpose of the Study:
- To isolate and characterize new diterpenoids from Boesenbergia maxwellii.
- To evaluate the biological activities of these novel compounds.
Main Methods:
- Isolation and purification of compounds using chromatographic techniques.
- Structure elucidation via spectroscopic methods (NMR, MS) and X-ray diffraction.
- Determination of absolute configuration using Electronic Circular Dichroism (ECD) spectroscopy.
Main Results:
- Three new diterpenoids, boesenmaxanes A-C (1-3), featuring a novel C-C bond between C-12 and an exocyclic methylene C-13, were identified.
- Boesenmaxanes A and C exhibited significant inhibitory activity against HIV in the syncytium reduction assay.
- EC50 values for boesenmaxanes A and C were determined to be 55.2 μM and 27.5 μM, respectively.
Conclusions:
- Boesenbergia maxwellii yields structurally unique diterpenoids.
- Boesenmaxanes A and C possess notable anti-HIV properties, warranting further investigation.
More Related Videos
Related Concept Videos
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.4K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.4K
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
930
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
930
01:19Antiasthma Drugs: Leukotriene Modifiers
1.5K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.5K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.4K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
01:24Antiasthma Drugs: Methylxanthines
1.4K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.4K